Feeling funky? Might be your gut trying to tell you something! Microbiologist Kiran Krishnan joined Janeane June 5 to talk about probiotics and more!

KUCI: Get the Funk Out

Recent research on probiotics shows even the most popular probiotics don’t survive our stomach acids and never make it into the intestines alive. The currently-exploding probiotic market is largely misunderstood and based on old information. According to microbiologist Kiran Krishnan, spore-forming bacillus strains have been prescribed medically in Europe and Asia for decades, exhibit amazing survivability and have huge therapeutic potential. A new study by Kiran on leaky gut will be published in the next few months in an international peer-reviewed journal and will open a new chapter on GI therapies and whole-body immunity. In addition, the NIH will be conducting a clinical trial on probiotics for HIV patients. Extensive work is also being done using spore-forming bacillus probiotics for children on the autism spectrum, most of whom have serious digestive problems. Kiran is a research microbiologist and has been involved in the dietary supplement and nutrition market for the past 16 years. He comes from a strict research background, having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. Kiran earned his Bachelor of Science degree in Microbiology at the University of Iowa; his undergraduate education was followed up with postgraduate research in Molecular Biology and Virology. He is a frequent lecturer on the human microbiome at medical and nutrition conferences and summits worldwide. He conducts the popular monthly Microbiome Series webinars through the Rebel Health Tribe Group practitioner training program, and is a frequent guest expert on national radio and satellite radio shows. He is currently involved in 3 novel human clinical trials on probiotics and the human microbiome. Krishnan is one of the most informed and articulate experts on the human microbiome in the world.